Spine device company withdraws $17M IPO: 4 key notes

Laura Dyrda -   Print  |

SpineEx withdrew its initial public offering at the end of last week, according to a Renaissance Capital report.


Here are four key points:

1. The company filed the $17 million IPO in September.

2. Without disclosing the reason, SpineEx withdrew its plans for the IPO.

3. Founded in 2017, the Fremont, Calif.-based spine device company received FDA clearance for its lateral lumbar interbody fusion device earlier this year.

4. Prior to its withdrawal, ThinkEquity was the sole bookrunner on the deal, according to the report.

More articles on spine devices:
Medtronic finalizes $1.7B Mazor acquisition: 5 key notes on what to expect next
Stryker, Zimmer Biomet, Smith & Nephew & more: 12 device company notes
Smith & Nephew to acquire Centrix Orthopaedics in $105M deal: 5 things to know

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers